HCPCS Level IIdrugActive
J7179
Vonvendi inj 1 iu vwf:rco
BETOS: O1E
Effective: 2017-01-01
Referenced in 3 policies
Description
Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vonvendi
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.